StockNYSE · US · USDBasic Materials · Specialty Chemicals
$IFF
INTERNATIONAL FLAVORS & FRAGRANCES INC
International Flavors & Fragrances, commonly known as IFF, creates and manufactures products used in food, beverage, health and biosciences, and scent applications, along with complementary products such as natural health ingredients. Its customers are principally manufacturers of food and beverages, personal care products, household and cleaning products, perfumes, dietary supplements, and animal nutrition products. IFF’s segments are Taste, Food Ingredients, Health & Biosciences, and Scent. Its offerings include flavor compounds and seasonings; specialty food ingredients, proteins and food protection ingredients; enzymes, cultures, probiotics and other specialty ingredients; and fragrance compounds and ingredients. It earns money by selling these products to manufacturers and, for some fragrance ingredients, to third parties. Its principal executive offices are in New York, New York and Wilmington, Delaware.
International Flavors & Fragrances Inc. opened its first Forest Lab in Brazil, identifying 33 Atlantic Forest species and capturing scents from 27 native plants. Eight scents have been recreated, according to the company.
IFF (NYSE: IFF), a global leader in flavors, fragrances, and biosciences, launched CONCEPT MUSE, an AI-powered platform for food and beverage concept generation. The tool uses consumer insights, market intelligence, and generative AI to accelerate innovation. IFF showcased the platform at its customer event, FirsTaste, demonstrating its ability to co-create product concepts. The launch aligns with IFF's broader digital transformation strategy.
International Flavors & Fragrances (IFF) reported Q3 revenue of $2B, up 5% YoY. EBITDA rose 6% to $403M, with margins expanding 20 bps. Management raised full-year targets but cited risks like soft Health markets and inflation. Free cash flow surged to $371M, and $500M in shares were repurchased. IFF expects Q4 growth to slow to 3% and margin pressure in Health & Biosciences.
via TradingView
IFF sentiment & insider activity
Over the past 7 days, AlphAI's AI scored 5 news stories mentioning IFF (INTERNATIONAL FLAVORS & FRAGRANCES INC). Coverage has skewed bullish: 2 bullish, 3 neutral, and 0 bearish.
Recent IFF coverage spans financial news, earnings and technology.
What's driving IFF
Near-term impact is likely limited because the article frames this as an operational step with no disclosed commercial adoption or revenue.
AlphAI scores every news story that mentions IFF with an AI model for sentiment and relevance, and aggregates insider trades from INTERNATIONAL FLAVORS & FRAGRANCES INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
International Flavors & Fragrances Inc. opened its first Forest Lab in Brazil, identifying 33 Atlantic Forest species and capturing scents from 27 native plants. Eight scents have been recreated, according to the company.
IFF (NYSE: IFF), a global leader in flavors, fragrances, and biosciences, launched CONCEPT MUSE, an AI-powered platform for food and beverage concept generation. The tool uses consumer insights, market intelligence, and generative AI to accelerate innovation. IFF showcased the platform at its customer event, FirsTaste, demonstrating its ability to co-create product concepts. The launch aligns with IFF's broader digital transformation strategy.
International Flavors & Fragrances (IFF) reported Q3 revenue of $2B, up 5% YoY. EBITDA rose 6% to $403M, with margins expanding 20 bps. Management raised full-year targets but cited risks like soft Health markets and inflation. Free cash flow surged to $371M, and $500M in shares were repurchased. IFF expects Q4 growth to slow to 3% and margin pressure in Health & Biosciences.
BofA downgraded International Flavors & Fragrances (IFF) to Underperform. The Nasdaq fell 5.52% in its worst day in 19 months, with AI-linked stocks hit hardest due to regulatory concerns. A strong jobs report increased Fed rate hike expectations to 78% for December.
International Flavors & Fragrances Inc (IFF) reported challenges in its Health business due to reduced consumer spending in the US and Europe. The company expects higher costs in Q4 2026, with net price to input costs remaining unfavorable. Profitability margins are expected to moderate due to seasonality and higher costs. IFF faces execution risks related to the separation of its Food Ingredients business.
Barclays kept Intl Flavors & Fragrances (IFF) at Overweight but reduced its price target to $103 from $105. This implies a 19.3% upside from the Nov 5 close of $86.36. Recent analyst price targets for IFF range from $95 to $108.
Analysts made several rating changes: Seaport upgraded SiTime (SITM) to Buy with a $425 target, citing AI cycle potential. Wells Fargo upgraded Becton Dickinson (BDX) to Overweight with a $242 target, expecting improved growth. Roth upgraded Centrus Energy (LEU) to Buy with a $115 target, noting acquisition benefits. JPMorgan upgraded SQM (SQM) to Overweight with a $71 target, seeing valuation support.
JP Morgan maintained its Overweight rating on Intl Flavors & Fragrances (IFF) and raised its price target to $95 from $92, suggesting a 10% upside from the Nov 5 close of $86.36. Recent analyst price targets for IFF range from $95 to $108.
Citigroup maintained its Buy rating on Intl Flavors & Fragrances (IFF) and raised its price target to $105 from $100, citing a 21.6% upside from the Nov 5 close of $86.36. Recent analyst price targets for IFF range from $95 to $108.